CUTR Stock Forecast 2025-2026
Distance to CUTR Price Targets
CUTR Price Momentum
🤔 Considering Cutera (CUTR)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest CUTR Stock Price Targets & Analyst Predictions
CUTR has shown a year-to-date change of -94.3% and a 1-year change of -99.0%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for CUTR. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CUTR Analyst Ratings
CUTR Price Target Range
Latest CUTR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CUTR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 9, 2024 | Stephens & Co. | George Sellers | Overweight | Maintains | $5.00 |
| Aug 9, 2024 | Piper Sandler | Matt O'Brien | Neutral | Reiterates | $1.00 |
| Jun 25, 2024 | Stephens & Co. | George Sellers | Overweight | Reiterates | $10.00 |
| Jun 21, 2024 | Piper Sandler | Matt O'Brien | Neutral | Maintains | $3.00 |
| Mar 22, 2024 | Stephens & Co. | George Sellers | Overweight | Reiterates | $10.00 |
| Mar 22, 2024 | William Blair | Margaret Kaczor | Market Perform | Upgrade | $0.00 |
| Mar 6, 2024 | Stephens & Co. | George Sellers | Overweight | Reiterates | $10.00 |
| Dec 22, 2023 | Stephens & Co. | George Sellers | Overweight | Reiterates | $10.00 |
| Nov 9, 2023 | Piper Sandler | Matt O'Brien | Neutral | Maintains | $3.00 |
| Nov 9, 2023 | Stifel | Jonathan Block | Buy | Maintains | $10.00 |
| Jul 27, 2023 | Piper Sandler | Matt O'Brien | Neutral | Upgrade | $18.00 |
| Jul 7, 2023 | Stifel | Jonathan Block | Buy | Maintains | $24.00 |
| Jun 12, 2023 | Stephens & Co. | Overweight | Reiterates | $0.00 | |
| May 16, 2023 | Stephens & Co. | George Sellers | Overweight | Reiterates | $42.00 |
| May 12, 2023 | William Blair | Underperform | Downgrade | $0.00 | |
| May 11, 2023 | William Blair | Margaret Kaczor | Underperform | Downgrade | $0.00 |
| May 10, 2023 | Cantor Fitzgerald | Louise Chen | Neutral | Maintains | $21.00 |
| May 10, 2023 | Piper Sandler | Matt O'Brien | Underweight | Reinstates | $14.00 |
| Apr 14, 2023 | Stephens & Co. | George Sellers | Overweight | Reiterates | $46.00 |
| Apr 10, 2023 | Stephens & Co. | George Sellers | Overweight | Reiterates | $46.00 |
Cutera Inc. (CUTR) Competitors
The following stocks are similar to Cutera based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Cutera Inc. (CUTR) Financial Data
Cutera Inc. has a market capitalization of $1.96M with a P/E ratio of 0.0x. The company generates $155.21M in trailing twelve-month revenue with a -92.6% profit margin.
Revenue growth is -30.1% quarter-over-quarter, while maintaining an operating margin of -111.4% and return on equity of +94.8%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Cutera Inc. (CUTR) Business Model
About Cutera Inc.
Develops innovative laser and energy-based aesthetic systems.
Cutera Inc. generates revenue by designing, manufacturing, and distributing advanced aesthetic systems for medical and cosmetic use. Their products cater to dermatologists, plastic surgeons, and aesthetic practitioners, facilitating various treatments such as hair removal, skin rejuvenation, and body sculpting.
Headquartered in Brisbane, California, Cutera is positioned in the rapidly growing aesthetic market, focusing on technology-driven solutions that meet the evolving demands of healthcare and beauty professionals.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
430
CEO
Mr. Taylor C. Harris
Country
United States
IPO Year
2004
Website
www.cutera.comCutera Inc. (CUTR) Latest News & Analysis
Cutera, Inc. will voluntarily delist its common stock from Nasdaq, planning to file a Form 25 with the SEC around March 20, 2025.
Cutera's voluntary delisting from Nasdaq may lead to decreased liquidity and investor confidence, impacting stock valuation and future funding opportunities.
Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success
10 days agoCutera, Inc. is initiating a restructuring to reduce debt by over $400 million (90%) and raise $65 million, with support from lenders holding 74% of its notes, to strengthen its balance sheet.
Cutera's restructuring reduces debt by over 90%, enhancing financial stability and potential for growth, which may positively influence investor confidence and stock performance.
The global dermatology devices market is projected to grow from $15.93 billion in 2024 to $18.38 billion in 2025, at a CAGR of 15.4%, driven by increased skin health awareness and aging population.
The projected growth of the dermatology devices market signals strong investment opportunities in healthcare, driven by rising demand and technological advancements, which can lead to higher returns.
Aesthetic Medicine enhances physical appearance using non-invasive to minimally invasive techniques, typically administered by various physicians with minimal anesthesia.
Growth in aesthetic medicine indicates rising consumer spending in healthcare and beauty sectors, potentially boosting revenue for companies involved in these treatments.
Cutera, Inc. (Nasdaq: CUTR) has partnered with the Adaptive Training Foundation to support individuals with physical impairments through exercise and community initiatives.
Cutera's partnership with the Adaptive Training Foundation enhances its brand image and community engagement, potentially boosting customer loyalty and sales in the aesthetic market.
Cutera, Inc. (CUTR) Q3 2024 Earnings Call Transcript
4 months agoCutera, Inc. (NASDAQ:CUTR) will hold its Q3 2024 earnings conference call on November 7, 2024, at 4:30 PM ET, featuring key company executives and analysts.
Cutera's Q3 earnings call on November 7, 2024, will provide insights into financial performance and strategic direction, impacting investor sentiment and stock price.
Frequently Asked Questions About CUTR Stock
What is Cutera Inc.'s (CUTR) stock forecast for 2025?
Analyst forecasts for Cutera Inc. (CUTR) are not currently available. The stock is trading at $0.02.
Is CUTR stock a good investment in 2025?
According to current analyst ratings, CUTR has 0 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.02. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CUTR stock?
Price predictions from Wall Street analysts for CUTR are not currently available. The stock is trading at $0.02.
What is Cutera Inc.'s business model?
Cutera Inc. generates revenue by designing, manufacturing, and distributing advanced aesthetic systems for medical and cosmetic use. Their products cater to dermatologists, plastic surgeons, and aesthetic practitioners, facilitating various treatments such as hair removal, skin rejuvenation, and body sculpting.
What is the highest forecasted price for CUTR Cutera Inc.?
Price targets from Wall Street analysts for CUTR are not currently available. The stock is trading at $0.02.
What is the lowest forecasted price for CUTR Cutera Inc.?
Price targets from Wall Street analysts for CUTR are not currently available. The stock is trading at $0.02.
What is the overall CUTR consensus from analysts for Cutera Inc.?
The overall analyst consensus for CUTR is neutral. Out of 8 Wall Street analysts, 0 rate it as Buy, 1 as Hold, and 0 as Sell.
How accurate are CUTR stock price projections?
Stock price projections, including those for Cutera Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
